Proving or Defeating Infringement Under the Doctrine of Equivalents: A Practical Guide

The Markman order lands on a Thursday afternoon. The court has construed "spring-biased" to require a metal spring, and the accused valve uses an elastomer sleeve. Literal infringement of the only claim your client cares about is finished. By Friday morning the general counsel has a question that sounds simple: "Don't we still have the doctrine of equivalents?"

Maybe. But the honest answer depends on documents from a decade ago, on a sentence in the specification nobody has reread since filing, and on whether your expert report from four months ago contains the words "way" and "why" in the right places. If you are on the other side of that case, the same three sources are where you can end it without a jury.

This guide is for both chairs. For the doctrine and its history, read the companion article, The Doctrine of Equivalents and Prosecution History Estoppel: When a Patent Reaches Beyond Its Literal Words. Here the goal is to tell you what to do, in what order, who should do it, and what it should look like when it is done.

The short answer

• Start with the file history, every time. Get the certified prosecution history of the patent and its family, then build a limitation-by-limitation estoppel table before you plead, answer, or opine. Most equivalents disputes are decided there.
• Patentee: disclose equivalents early, specifically, and limitation by limitation. A boilerplate reservation in contentions can cost you the theory, and an expert who says "design choice" will lose the verdict on appeal.
• Accused infringer: attack in layers. Estoppel and disclosure-dedication first, on the pleadings if the record is clean. Then ensnarement and vitiation at summary judgment. Then the "way" prong and the particularity of the proof, preserved under Rule 50.
• Know who decides what. Equivalence is for the jury. Estoppel, its rebuttal, dedication, ensnarement, and vitiation are for the court. Plan the schedule around that split, and ask for it in the case management order.
• Get special verdicts by limitation. The Supreme Court suggested them, and they matter on appeal.
• Fix what you can in prosecution. If an application or continuation is still pending, the cheapest equivalents strategy available is a literal claim.

The sequence at a glance

Step 1: Build the estoppel history before anything else

Who: a litigation associate or patent agent, reviewed by someone with prosecution experience. When: before the complaint, or within days of receiving a complaint or notice letter.

Order the certified file wrapper for the asserted patent and every application in its priority chain. Include continuations, divisionals, any reexamination or reissue, and any inter partes review record. Public Patent Center data is a good start, but anything you intend to file with a court should come from a certified copy. Do not rely on someone's summary.

Then, for each claim limitation you expect to matter, record:

1. Original language and every later version, with dates.
2. Each rejection tied to that language and the statutory basis.
3. Each amendment, including added limitations, rewritten dependents, and canceled claims.
4. Each statement to the examiner touching the limitation or the difference between the claim and the art.
5. The reason for the amendment that an outside reader could discern from the record, and nothing more.
6. Whether the accused feature falls in the territory between the original and amended language.
7. What the specification says about alternatives to this limitation.

A template is in the Doctrine of Equivalents Toolkit: Claim Charts, Estoppel Histories, and Ensnarement Analyses. Fill it in honestly, because this table drives everything else. Look specifically for these traps.

Rewritten dependents. If an allowed dependent was rewritten as independent and the parent was canceled, the added limitation carries the presumption. Honeywell International Inc. v. Hamilton Sundstrand Corp., 370 F.3d 1131 (Fed. Cir. 2004) (en banc) is the authority, and Felix v. American Honda Motor Co., 562 F.3d 1167 (Fed. Cir. 2009) shows how little room remains to explain it away.

Canceled sibling claims. Do not stop at the asserted claim's history. Colibri Heart Valve LLC v. Medtronic CoreValve, LLC, No. 23-2153 (Fed. Cir. July 18, 2025) found narrowing where the applicant canceled a separate independent claim whose subject matter was closely related to the retained claim. A verdict of more than $106 million was reversed on that ground.

Arguments that outran the amendment. Search remarks for words like "particular," "only," "requires," and "unlike." In Amgen Inc. v. Coherus BioSciences Inc., 931 F.3d 1154 (Fed. Cir. 2019), emphasis on "particular combinations" of salts was enough for a clear and unmistakable surrender, even though the claims issued after a later response that did not repeat the point. On the other hand, arguments are read less aggressively than amendments. Conoco, Inc. v. Energy & Environmental International, L.C., 460 F.3d 1349 (Fed. Cir. 2006) notes that no presumption treats an argument as giving up an entire field of equivalents.

Family history. Estoppel can reach related patents in the same lineage, but differences in the claims and disclosures can stop it, as in Trading Technologies International, Inc. v. Open E Cry, LLC, 728 F.3d 1309 (Fed. Cir. 2013). Read the parent's file and then explain why it does or does not carry over.

Post-grant statements. Under Aylus Networks, Inc. v. Apple Inc., 856 F.3d 1353 (Fed. Cir. 2017), what a patent owner says in an IPR can support prosecution disclaimer. Patent owners defending an IPR while asserting equivalents in court need one voice across both proceedings. See Filing or Defending an Inter Partes Review: A Practical Guide.

Should you call the prosecuting attorney? The patentee may want to, for context, but understand the limit. Under Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 344 F.3d 1359 (Fed. Cir. 2003) (en banc), the reason for an amendment is judged from the record, so a declaration about what counsel was thinking years ago will not rescue a tangentiality argument. The accused infringer may also think about a prosecution counsel deposition, but in most cases the file speaks for itself, and the bigger payoff is elsewhere.

Step 2: Sort each limitation into green, yellow, or red

With the table complete, sort each limitation where equivalence is needed.

• Red: estoppel on its face. The limitation was added or narrowed for patentability, the accused feature is in the surrendered territory, and the feature appears in the cited art or the original claim. A patentee should think hard before pleading this. An accused infringer should move early.
• Yellow: rebuttal needed. A narrowing amendment exists, but the accused difference lies on a different axis from the reason for the amendment, or the alternative may be later-developed technology. A patentee can proceed with a real argument. An accused infringer should expect a contest.
• Green: original, unamended language. No estoppel. Go on to dedication, vitiation, ensnarement, and proof.

Next, ask the dedication question for every limitation. Does the specification name the accused alternative, with enough specificity that a skilled reader would see it as an alternative to the limitation? If so, Johnson & Johnston Associates Inc. v. R.E. Service Co., 285 F.3d 1046 (Fed. Cir. 2002) (en banc) ends that theory, and Actelion Pharmaceuticals Ltd v. Mylan Pharmaceuticals Inc., No. 24-1641 (Fed. Cir. May 13, 2026) shows that even "preferably" language can do it, with overlapping alternatives. A generic reference is less dangerous: in Eli Lilly & Co. v. Hospira, Inc., 933 F.3d 1320 (Fed. Cir. 2019), a generic formula in a patent mentioned in the specification did not dedicate the specific salt.

Worked hypothetical: the spring-biased valve

Suppose Corwin Fluid Controls holds a patent claiming a pressure-relief valve with "a poppet spring-biased against a seat." Its competitor, Ansel Hydraulics, uses an elastomer sleeve that compresses and urges the poppet closed. The Markman order reads "spring-biased" to require a metal coil or leaf spring. Corwin's team pulls the history and finds three scenarios to test.

If the original claim said "a poppet biased against a seat," and the examiner rejected it over a reference with an elastomer diaphragm, the elastomer is both in the surrendered territory and in the art. That is red. Corwin should drop equivalents and put its resources into other claims, a continuation if one is pending, or another patent.

If the original claim said "biased" and the reference used a gravity-seated poppet, Corwin can argue the amendment concerned biasing versus gravity and has nothing to do with spring material. But an elastomer biasing element falls in the territory, and elastomers were surely known, so foreseeability is out. Corwin has only tangentiality, it must make that argument from the record alone, and it faces the point that the limitation the applicant chose is "spring." That is yellow, and on the darker end.

If "spring-biased" was in the original claim and the specification never mentions elastomers, the theory goes forward. Corwin needs an engineer to explain how compression of a sleeve and compression of a coil provide substantially the same force curve and closing response in this valve. Ansel will answer with hysteresis, temperature sensitivity, and aging differences. If Ansel's engineering notes show those were the reasons for the design, those notes are excellent "way" evidence. Corwin can use its own: if the trade literature describes the sleeve as a drop-in substitute, known interchangeability helps it under Graver Tank & Mfg. Co. v. Linde Air Products Co., 339 U.S. 605 (1950).

Step 3: Pre-suit analysis and pleading

Patentee. A Rule 11 inquiry under Fed. R. Civ. P. 11 on an equivalents theory should include the estoppel table. Literal infringement remains the lead theory where possible. Where equivalence is needed, plead facts rather than the label, and identify the limitation.

Sample allegation, to adapt:

To the extent the [accused product] does not literally include "[limitation]," it includes [specific structure or step], which performs substantially the same function of [function] in substantially the same way, by [how], to obtain the same result of [result]. The differences between [accused feature] and "[limitation]" are insubstantial because [reasons]. [Limitation] was not added or narrowed by amendment during prosecution of the [patent number] patent, and the specification does not describe [accused feature] as an alternative to it.

That last sentence is optional. It tells the court you have looked, and it commits you, so include it only if it is true after real review.

Accused infringer. Do not assume these limits must wait for summary judgment. In Coherus the court affirmed dismissal under Fed. R. Civ. P. 12 based on the prosecution history, and in Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC, 958 F.3d 1171 (Fed. Cir. 2020) it affirmed judgment on the pleadings on disclosure-dedication. Both are pharmaceutical disputes with clean records, and some judges will want more before ruling. The trade-offs are worth a conversation:

• A win ends the theory early and shapes settlement.
• A loss can educate the patentee and produce a written order saying the theory is plausible.
• Moving early may give up the surprise of a later motion, though a sophisticated patentee will see it coming anyway.
• You need a real record: the file history, attached or subject to notice, and claim language that does not need construction to decide the issue.

Preserve prosecution history estoppel as a defense in the answer. Then be careful with the pretrial statement. In Colibri, Medtronic told the court in a pretrial memorandum that it was "not pursuing" the estoppel defense, then raised it in its Rule 50 motions. The Federal Circuit reached the merits anyway, finding no waiver in the circumstances, because the district court had addressed the merits and no prejudice was shown. Do not count on that generosity.

Step 4: Infringement contentions

Local patent rules in many districts require disclosure of equivalents theories. The Northern District of California's Patent L.R. 3-1 asks whether each limitation is alleged to be literally present or present under the doctrine of equivalents, and the Eastern District of Texas's Patent Rule 3-1 is similar. Rules vary by court and change, so check the current version and the judge's standing order. Where no local rules apply, serve an interrogatory or ask for the same disclosure in the Fed. R. Civ. P. 16 schedule.

Patentee. The common form of contention is a boilerplate sentence at the end of a chart: "To the extent any limitation is not literally met, it is met under the doctrine of equivalents." Courts applying local patent rules can find such language inadequate, and it may leave you without a theory at trial. Practice varies, so read your judge's recent orders. Write this instead:

[Limitation 1(c): "a poppet spring-biased against a seat."] Literal: [position, if any, under the proposed construction]. Equivalents: The [elastomer sleeve, part no.] performs the function of holding the poppet against the seat until system pressure exceeds a set value. It does so in substantially the same way, by storing elastic energy under compression and applying that restoring force along the poppet axis, as shown in [Bates range] and [test report]. It achieves the same result, relief at the set pressure with reseating on pressure drop. See [expert or engineering source when available]. This contention is based on information available to date and will be supplemented upon production of [items].

Update contentions after the Markman order. Many rules allow amendment on a showing of good cause, often including an adverse or unexpected claim construction, and speed matters. Do not spend three months deciding.

Accused infringer. Answer specifics with specifics. If the contention is boilerplate, send a deficiency letter early, then move to strike or compel. At the end of discovery, use the same record to oppose any new theory that surfaces in an expert report. In Jang v. Boston Scientific Corp., 872 F.3d 1275 (Fed. Cir. 2017), a motion in limine arguing that the patentee was merely rehashing his literal theory was denied because the expert reports explained the theory. So the motion needs more than a label. Compare what was disclosed with what is now being argued, and show the prejudice.

Step 5: Fact discovery aimed at the equivalents issues

Patentee's targets:

• Engineering documents describing the accused feature and why it was chosen, including test data comparing it with the claimed alternative. Comparisons by the defendant's own engineers are usually the best evidence available.
• Marketing, regulatory, or customer statements that the accused feature is interchangeable with the claimed one. Lilly relied in part on defendants' statements to the FDA that their salt choice was immaterial.
• Trade literature showing known interchangeability at the time of infringement. Warner-Jenkinson Co. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997) makes that the relevant time for equivalence.
• For software, source code and architecture documents, with an engineer deposed about what each module does and when. A diagram of the actual data and control flow is worth more than ten slide decks.

Accused infringer's targets:

• What the inventors knew and considered at filing. Under Wm. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356 (Fed. Cir. 2012) and UCB, Inc. v. Watson Laboratories Inc., 927 F.3d 1272 (Fed. Cir. 2019), evidence that the inventor knew of an alternative and claimed around it may help, though it is no per se bar.
• The patentee's own statements that its invention differs from alternatives such as the accused one, in marketing, in other litigation, in foreign prosecution.
• Prior art for ensnarement, including art not before the examiner. The accused infringer carries the burden of production on this art.
• Facts about when the alternative became known for foreseeability, which may include publications, product sales, and invoices. Duramed Pharmaceuticals, Inc. v. Paddock Laboratories, Inc., 644 F.3d 1376 (Fed. Cir. 2011) rested on a published application and was reinforced by sales records.

Intent and copying. Intent plays no role in the doctrine under Warner-Jenkinson, but both sides will still want the facts. An accused infringer's design-around documents can show deliberate engineering differences. Willfulness evidence may overlap, and privilege issues can get complicated if opinion counsel was involved. For that side, see Managing Willfulness Risk After a Patent Notice Letter: A Practical Guide. Design-history productions are also a common place for privileged notes to slip out, so have a plan under Recovering an Inadvertently Produced Privileged Document: A Practical Guide.

Step 6: The expert report

This is where patent owners lose cases they had a right to win. The standard comes from Texas Instruments Inc. v. Cypress Semiconductor Corp., 90 F.3d 1558 (Fed. Cir. 1996): particularized testimony and linking argument, limitation by limitation. Generalized testimony of overall similarity will not do. VLSI Technology LLC v. Intel Corp., 87 F.4th 1332 (Fed. Cir. 2023) and NexStep, Inc. v. Comcast Cable Communications, LLC, 119 F.4th 1355 (Fed. Cir. 2024) have made clear that this is not a technicality. The report must satisfy Fed. R. Civ. P. 26(a)(2)(B) and Fed. R. Evid. 702. For expert practice generally, see Expert Witnesses After the 2023 Amendment to Rule 702: Daubert, Disclosure, and Cross-Examination.

What a good report does for each limitation under equivalents:

1. States the limitation as construed, and what is not literally met and why.
2. Identifies the specific accused structure or step, with citations.
3. Explains the role of the limitation in the claim as a whole, since Warner-Jenkinson says the role played by each element informs the analysis.
4. Addresses each of function, way, and result separately for both the claimed element and the accused element, explaining what they are and why they are substantially the same. That formulation comes from Malta v. Schulmerich Carillons, as quoted in NexStep.
5. Addresses the differences head on, including those the other side will raise, and explains why they are insubstantial in this context.
6. Addresses known interchangeability with evidence.
7. Does not read out the limitation: tests the theory by asking what would not be equivalent.

Language to avoid and language to use.

Why so much fuss? Because in VLSI the expert testified that one module and another were separated by "just a difference of where an engineer draws this data line," and that was the record the jury relied on. A $675 million verdict was reversed. In NexStep, the patentee argued that the technology was simple enough for a jury without such testimony, and the court disagreed. Judge Reyna's partial dissent argues that this creates a new always-need-an-expert rule. The majority denied that it had created such a rule, but plan as if its view controls, because it does: the full court denied rehearing en banc and the Supreme Court denied certiorari in 2025.

Worked hypothetical: the fraud score

Suppose Larkspur Payments holds a patent claiming "comparing a transaction score to a stored threshold and, when the score exceeds the threshold, routing the transaction to a review queue." The accused system, from Tessel Commerce, feeds the same inputs to a gradient-boosted model that outputs a routing decision directly, with no explicit stored threshold. Before calling this equivalent, look at what happens at the system level.

Larkspur's system computes a number, reads a configured value from storage, and does a comparison. An operator can change the threshold without retraining anything. Tessel's system encodes the decision boundary inside many decision trees, effectively many stored comparisons at internal nodes, and changing the behavior means retraining or recalibrating.

Larkspur's best case: the model output is functionally a score plus a boundary, and the internal node comparisons are stored thresholds in substance; the function (separate risky transactions), the way (numeric comparison against learned stored values), and the result (routing) match. Its expert would need to walk through an actual decision path in the code with actual inputs.

Tessel's best case: the claim's stored threshold is a single configurable operating point, and that configurability is what the specification praises. A model with no such point works differently in the way that matters. Tessel also checks the file. If the applicant added "stored threshold" to overcome a reference that used a statistical model, the theory is barred before any of that testimony is needed. If the specification says "machine-learned models may alternatively be used," dedication applies. Machine learning was known at the time, so a foreseeability argument would likely fail if there had been a narrowing amendment.

And a word for Tessel about the Larkspur argument that the claim "should be read" to cover new technology. Warner-Jenkinson measures equivalence at infringement, so later-developed techniques can qualify. Tessel should therefore focus on differences in operation, not on the newness of the technique.

Step 7: Pretrial motions on the legal limits

Footnote 8 of Warner-Jenkinson tells courts to decide legal limitations on summary judgment or JMOL, and to grant summary judgment where no reasonable jury could find equivalence. Use it. Under Fed. R. Civ. P. 56, the accused infringer's motion should proceed in the following order, because each ground is independent and each later one needs more fact.

1. Prosecution history estoppel. Show the amendment, the narrowing, the patentability reason, and the location of the accused feature in the surrendered territory. Then the burden is on the patentee. Under Festo, the patentee must rebut by a preponderance, as Integrated Technology Corp. v. Rudolph Technologies, Inc., 734 F.3d 1352 (Fed. Cir. 2013) says. Sample framing:

The original claim recited [X]. After the examiner rejected it under [§ 102 or § 103] over [reference], the applicant amended the claim to recite [Y]. The amendment narrowed the claim and was made for a reason related to patentability, so [patentee] is presumed to have surrendered the territory between [X] and [Y]. [Accused feature] lies in that territory because [reason]. [Patentee] cannot rebut the presumption: [accused feature] was known in the field at the time of the amendment, as shown by [source]; the amendment's objectively apparent reason was [reason], which is directly related to the accused difference; and no shortcoming of language prevented the applicant from describing it.

2. Disclosure-dedication. Quote the specification. Show the disclosure names the alternative, with specificity, as an alternative to the limitation, under PSC Computer Products, Inc. v. Foxconn International, Inc., 355 F.3d 1353 (Fed. Cir. 2004) and Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc., 429 F.3d 1364 (Fed. Cir. 2005). Show it is unclaimed.

3. Vitiation. Frame this as no reasonable jury, per Deere & Co. v. Bush Hog, LLC, 703 F.3d 1349 (Fed. Cir. 2012). Do not call the element binary or say it is simply "missing." Explain the work the limitation does and show that the theory leaves nothing of it. Freedman Seating Co. v. American Seating Co., 420 F.3d 1350 (Fed. Cir. 2005) and Akzo Nobel Coatings, Inc. v. Dow Chemical Co., 811 F.3d 1334 (Fed. Cir. 2016) are the models. Note that a district court's vitiation ruling was reversed with instructions to enter infringement in Ring & Pinion Service Inc. v. ARB Corp., 743 F.3d 831 (Fed. Cir. 2014), so this one can backfire if overplayed.

4. Ensnarement. See Step 8.

5. Failure of proof. Point to the expert report and show what is absent. Akzo affirmed summary judgment where the expert's statement on "way" was conclusory.

Patentee's opposition. Lead with whichever gate is weakest for the defendant. On estoppel, line up the two axes from Ajinomoto Co. v. International Trade Commission, 932 F.3d 1342 (Fed. Cir. 2019): the objective reason for the amendment, and how the accused feature departs from the literal claim. Then argue they are different. Use the record, cite Lilly, and address the reference directly, because courts read amendments in the context of the art that prompted them. On foreseeability, put in actual evidence of the state of the art. Expert testimony is permitted there, but remember the tests from Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 493 F.3d 1368 (Fed. Cir. 2007) and Honeywell International, Inc. v. Hamilton Sundstrand Corp., 523 F.3d 1304 (Fed. Cir. 2008): suitability for the amended claim's purpose is not required for foreseeability, and you cannot define the equivalent one way for infringement and another for foreseeability.

Ask for sequencing. Festo issues, dedication, and ensnarement are for the court. Either side can ask to have them decided with or just after claim construction, particularly if a decision could remove a large part of the case. Some commentators have suggested combining a Festo determination with the Markman hearing. Whether that makes sense depends on how much fact development foreseeability needs, and on the judge. Include your request in the Rule 26(f) report and the proposed schedule, and for hearing preparation, see Preparing for a Markman Hearing: A Practical Guide.

Worked hypothetical: the numeric coating range

Suppose Dalton Coatings claims a corrosion-resistant paint with "zinc in an amount of 30 to 40 percent by weight." The accused paint from Fennimore Finishes has 28.5 percent zinc. Under Adams Respiratory Therapeutics, Inc. v. Perrigo Co., 616 F.3d 1283 (Fed. Cir. 2010), a numeric limit does not automatically preclude equivalents. Dalton files suit. Fennimore's first move is the file. Say the original claim recited "zinc in an effective amount," and the applicant added 30 to 40 percent after a rejection over a reference disclosing 15 to 25 percent. Under Biagro Western Sales, Inc. v. Grow More, Inc., 423 F.3d 1296 (Fed. Cir. 2005), where both the reason for the amendment and the equivalent concerned the same variable, the amendment was not tangential. Under Festo, 28.5 percent is in the surrendered territory. Fennimore should win on summary judgment.

Change one fact: suppose 30 to 40 percent was in the original claim. Then Warner-Jenkinson and Adams allow the argument, the question is how much of a difference is insubstantial, and test data on corrosion performance at 28.5 percent will matter. Ensnarement now matters too: a hypothetical claim reaching 28.5 percent must also clear the 15 to 25 percent reference, and if the art's teaching would make 28 percent obvious, the claim is in trouble. Dalton will want to keep the hypothetical range as tight as possible, such as 28 to 40 percent, since a broader one catches more art.

Step 8: Ensnarement and the hypothetical claim

The law. Wilson Sporting Goods Co. v. David Geoffrey & Associates, 904 F.2d 677 (Fed. Cir. 1990) created the hypothetical claim tool. DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc., 567 F.3d 1314 (Fed. Cir. 2009) assigns the question to the court. Intendis GmbH v. Glenmark Pharmaceuticals Inc., 822 F.3d 1355 (Fed. Cir. 2016) describes the two steps: construct a claim that literally covers the accused device, then determine whether the patentee has carried its burden of showing it patentable over the prior art the accused infringer introduces.

Patentee's steps:

1. Draft the hypothetical claim yourself, before someone asks. Start with the actual claim, and broaden only the limitation at issue, just enough to literally cover the accused feature.
2. Add nothing narrowing. Jang and Streamfeeder, LLC v. Sure-Feed Systems, Inc., 175 F.3d 974 (Fed. Cir. 1999) forbid it. Jang lost a verdict because one proposed claim added a flexibility limitation and the other broadened nothing. And the court had no duty to fix it for him.
3. Run the claim through §§ 102 and 103 against the art as if prosecuting it, with an expert ready to explain why a skilled person would not have arrived at it. In Intendis, the record that the art would not have led to the substitution and offered no reasonable expectation of success carried the day.
4. Remember that § 112 issues can also come up, as they would for an actual claim.

Accused infringer's steps:

1. Raise the defense early, in the answer or in response to contentions, and identify the art. Jang found no waiver and no prejudice from a post-trial hearing, but your court's schedule may be less forgiving.
2. Demand the hypothetical claim in an interrogatory. Then test it: Is it broader in every respect? Does it literally cover your product? Is it truly confined to the asserted equivalent?
3. Build the prior art record, with a technical expert, as you would for obviousness. The standard of persuasion favors you, compared with an invalidity defense: the patentee bears the burden, and you need not prove anything by clear and convincing evidence. Consider coordinating with your invalidity contentions. For the art itself, see Finding, Qualifying, and Using Prior Art: A Practical Guide.
4. Consider asking the court to hold a separate bench proceeding on ensnarement either before trial (which may eliminate the theory) or after a verdict (which may be more efficient). DePuy and Jang both involved post-verdict determinations.

Note the interaction with an ex parte reexamination or IPR. A PTO decision confirming the actual claims does not answer the ensnarement question, since the hypothetical claim is broader. In DePuy, a reexamination confirmation arrived after the ensnarement ruling. Take care with any argument that it decides the matter.

Step 9: Trial

Case presentation (patentee). The evidence must be particular to each limitation and delivered through a skilled witness. Do not rely on the jury to connect the dots between the expert's literal testimony and an equivalents theory: the "linking argument" requirement means someone must actually do the linking. An opening sentence such as "even if not literal, it is the same" invites the error the cases warn about.

Case presentation (accused infringer). Keep the focus on what differs in operation, and show the reason for the engineering choice. Cross-examine on way, and on the actual limitation. Ask the expert to identify what would not be equivalent. Move in limine against equivalents theories outside the contentions and report.

Rule 50(a). At the close of the patentee's case, move under Fed. R. Civ. P. 50 with specifics: identify the limitation, identify the absence of particularized testimony on function, way, or result, and state each legal limit you rely on. Renew under Rule 50(b) after the verdict. Without this, you may be limited to much weaker arguments on appeal. Keep estoppel alive throughout, and consider a separate request for findings. Medtronic won in Colibri on the strength of a legal argument pressed in Rule 50 motions, despite the earlier pretrial statement.

Jury instructions and verdict form. Ask for instructions that say each limitation must be met literally or by an equivalent, and that the jury may not find infringement because the products are overall similar. Sample verdict question, drawing on Fed. R. Civ. P. 49:

Question 3. For each limitation below that you did not find literally present in the [accused product], has [patentee] proved by a preponderance of the evidence that the [accused product] contains an equivalent? (a) "[limitation 1(b)]": Yes ___ No ___ (b) "[limitation 1(c)]": Yes ___ No ___

Both sides should think about this. A limitation-specific verdict makes review cleaner, which helps a defendant on a thin record and may protect a patentee where only one limitation is weak. Footnote 8 of Warner-Jenkinson recommended this approach. A general verdict leaves the appellate court to guess, and that can cut either way.

Bench trial. If the case is tried to the court, as in many Hatch-Waxman cases, equivalence review is for clear error, a significant advantage for whoever wins below. Lilly and UCB both affirmed bench findings of equivalence. For that setting, see Running an ANDA Litigation: A Practical Guide.

Step 10: Post-trial motions and appeal

Appeals go to the Federal Circuit under 28 U.S.C. § 1295. Federal Circuit law governs the substantive patent issues and the estoppel question, while the regional circuit's law supplies the JMOL standard.

Patentees who lost a literal claim-construction ruling should remember that an improved construction on appeal can reopen equivalents too. That was the result in Deere, where the error in construction also undid the district court's equivalents ruling. For the mechanics of the post-trial motions, see Filing or Opposing Post-Trial Motions Under Rules 50, 59, and 60: A Practical Guide and Post-Trial Motion Checklist: A Practical Checklist. A verdict on equivalents can also carry enhanced damages; Integrated Technology shows that reversal of the equivalents finding took the willfulness finding and treble damages with it. For damages exposure generally, see Patent Damages: Reasonable Royalties, Lost Profits, Apportionment, and Enhancement.

Prosecution lessons: fixing the file before it matters

If you are writing or amending claims, you can act on all of this now, for a very small fraction of what the fight costs later. Coordinate with Drafting Patent Claims and Specifications That Survive Section 112: A Practical Guide and Responding to Patent Office Actions: Strategies for Overcoming Rejections.

Claim alternatives. Every embodiment you describe as an alternative should be in a claim somewhere, with its own support, or you should accept that it is gone. Johnson & Johnston lost steel to one sentence. The trade-off is examination friction: broader claims may draw more rejections, and that is exactly what the court said the rule is for.

Keep a continuation alive. If you can, keep at least one application pending in the family so that claims can be drafted literally to reach what the market builds. Johnson & Johnston expressly notes this route, along with a broadening reissue within two years under 35 U.S.C. § 251. Reissue has its own limits, including the recapture rule, so do not treat it as a free retry.

Think twice about the easy allowance. An examiner's note that a dependent claim would be allowable if rewritten is tempting. After Honeywell, taking it creates a presumption for what the dependent claim added. Alternatives include appealing, arguing the broader claim further, or taking the allowance while pursuing broader claims in a continuation. Do remember that a surrender in one application may be read against later family members, so treat the family as one record.

Write remarks to survive a later reader. Say what the reference lacks and how the amendment addresses it, in a way tied to the reference's actual teaching. Avoid characterizing the invention more broadly than needed. Avoid superlatives and "the present invention requires." Do not repeat words like "particular" unless you mean them to limit.

Weak: "The present invention requires a particular combination of X and Y, unlike the prior art." Better: "[Reference] does not disclose [specific feature recited in the claim]. Claim 1 as amended recites [feature]. Applicant makes no statement about other features and reserves the right to pursue other claims in this or a related application."

Be realistic: a general reservation does not undo a clear surrender, and the amendment itself still carries the presumption. What such language does is limit the argument-based estoppel risk and provide a record for a tangentiality argument, since that argument is decided on what the file shows. A clear statement of the objective reason for an amendment is the only evidence you will have.

Cancellation is not neutral. After Colibri, canceling a claim with closely related subject matter can narrow what is left. Whether "without prejudice" language would help in a Colibri setting has not been resolved. Consider instead whether to pursue the rejected subject matter in a continuation with better support, or address the § 112 rejection directly.

Restriction practice. Under UCB, a restriction election does not necessarily trigger estoppel. Traversing and being clear about what was elected helps. In design applications, canceling figures in response to a restriction may surrender those designs under Pacific Coast Marine Windshields Ltd. v. Malibu Boats, LLC, 739 F.3d 694 (Fed. Cir. 2014). File separate applications for alternative designs, and see Design Patent Toolkit: A Roadmap for Protecting How a Product Looks.

Consider appeal. The Supreme Court noted in Festo that a decision to forgo an appeal and submit an amended claim is taken as a concession that the invention does not reach as far as the original claim. For a core limitation, an appeal may cost less than a permanent loss of equivalents.

Audit means-plus-function claims. Under § 112(f), equivalents are assessed at issuance, which means they cannot reach after-arising technology, whereas the doctrine of equivalents can. A software drafter who wants coverage over later technology should understand what each form provides. See Section 112 Toolkit: Claim Support Charts, Invalidity Contentions, and Expert Declarations.

Costs and trade-offs

Budget figures vary too widely by forum and technology for a useful number here, but the relative weights are consistent.

• File history review is cheap and almost always pays for itself. Do it even for a defensive assessment of a demand letter.
• A technical expert's equivalents work is a meaningful extra cost on top of a literal infringement opinion, since each limitation needs function, way, and result with reasons and evidence. A patentee whose literal case is strong must still decide whether to spend it as insurance. Usually the answer is yes, for the limitations most exposed to claim construction.
• Ensnarement adds hypothetical claim drafting and a mini-prosecution analysis. Often it also adds a bench hearing.
• An early Rule 12 motion is inexpensive compared with summary judgment after expert discovery, but it risks an unhelpful order.
• For patentees, equivalents-only cases carry heightened appellate risk. A large verdict on equivalents alone is more exposed than a similar verdict on literal infringement. VLSI, Colibri, and Integrated Technology each show that risk. Factor it into settlement.
• For accused infringers, a strong legal-limit argument has settlement value early, because it is reviewed de novo. But it does not eliminate the risk of a verdict in the meantime, and the time and cost of appeal are real.

Common mistakes

Patentee side:

1. Pleading equivalents before reading the file history.
2. Relying on boilerplate in contentions and then being surprised at a motion to strike.
3. Having the expert present equivalents as a brief add-on to literal infringement, with no separate treatment of way.
4. Defining the equivalent narrowly for infringement and broadly for foreseeability, or the reverse. Honeywell (2008) forbids that.
5. Relying on a declaration about what the attorney meant, on tangentiality.
6. Drafting a hypothetical claim that adds a limitation to dodge the art.
7. Relying on "it's a simple technology, the jury can see it." NexStep rejects that.
8. Failing to look at sibling claims canceled during prosecution.

Accused infringer side:

1. Treating a literal non-infringement opinion as the end of the analysis. Equivalents needs its own attention, and the freedom-to-operate work should cover it. See Freedom to Operate and IP Clearance Toolkit: Clearing the Path Before You Launch.
2. Arguing vitiation as "the element is missing." Deere calls this a misperception.
3. Arguing foreseeability as a free-standing bar. Ring & Pinion rejects that. Foreseeability belongs in the Festo analysis and, at most, as a factor elsewhere.
4. Failing to make specific Rule 50(a) motions on the way prong and the limits.
5. Abandoning estoppel in a pretrial statement by accident. Colibri came out well for the defendant, but the fight was avoidable.
6. Failing to raise ensnarement with art before the end of fact discovery.
7. Writing internal documents describing a design-around as "the same thing but outside the claims." Intent is irrelevant under Warner-Jenkinson, but such a document will still come up at trial.
8. Assuming that only a legal limit can win. The way prong, tested with a real engineer's explanation of why the design differs, often persuades a jury too.

A short note on software and systems

When the accused system moves a function across a boundary, whether client to server, hardware to firmware, or one module to another, take the time to build a real architecture exhibit. VLSI turned on what software module did what. A skilled witness should be able to say what state lives where, what triggers what, and what follows from the difference, in terms of timing, failure modes, or scale. Pennwalt Corp. v. Durand-Wayland, Inc., 833 F.2d 931 (Fed. Cir. 1987) (en banc) made the point long ago: replacing hard-wired circuits with a computer may matter less than whether the claimed functions are actually performed. And in means-plus-function claims, compare against the disclosed algorithm under WMS Gaming Inc. v. International Game Technology, 184 F.3d 1339 (Fed. Cir. 1999). For a complex indirect infringement overlay, where customers perform the method, see Indirect and Divided Patent Infringement: Inducement, Contributory Liability, and the Akamai Problem; Colibri itself was an inducement case resting on equivalents. Venue is a separate matter, covered in Choosing or Challenging Venue in a Patent Case: A Practical Guide and Patent Venue After TC Heartland: Regular and Established Places of Business, Foreign Defendants, and Transfer.

This guide is general and does not take the place of advice on a particular patent or product. Equivalents disputes reward early work, so if a Markman ruling or a demand letter has just put the question on your desk, a file history review is the sensible first call.

Related Documents

Related Articles

• The Doctrine of Equivalents and Prosecution History Estoppel: When a Patent Reaches Beyond Its Literal Words: the doctrine, its history, and the leading cases in depth.
• How to Read a Patent: Claims, Specification, and Prosecution History: how to read the file this guide tells you to order first.
• Inter Partes Review Strategy: Discretionary Denial, Estoppel, and the Parallel District Court Case: coordinating statements across a parallel IPR.
• Expert Witnesses After the 2023 Amendment to Rule 702: Daubert, Disclosure, and Cross-Examination: admissibility standards for the expert this guide relies on.
• Patent Damages: Reasonable Royalties, Lost Profits, Apportionment, and Enhancement: what is at stake if an equivalents verdict holds.
• Patent Venue After TC Heartland: Regular and Established Places of Business, Foreign Defendants, and Transfer: the venue doctrine, from this batch's venue cluster.

Related Guides

• Preparing for a Markman Hearing: A Practical Guide: the proceeding that usually triggers the equivalents question.
• Drafting Patent Claims and Specifications That Survive Section 112: A Practical Guide: drafting lessons that pair with the prosecution section.
• Filing or Opposing Post-Trial Motions Under Rules 50, 59, and 60: A Practical Guide: Rule 50 and post-trial mechanics.
• Filing or Defending an Inter Partes Review: A Practical Guide: post-grant practice and patent owner statements.
• Finding, Qualifying, and Using Prior Art: A Practical Guide: finding the art used for ensnarement.
• Managing Willfulness Risk After a Patent Notice Letter: A Practical Guide: responding to a notice letter that includes an equivalents theory.
• Choosing or Challenging Venue in a Patent Case: A Practical Guide: where the case can be brought, from this batch's venue cluster.
• Running an ANDA Litigation: A Practical Guide: bench-tried equivalents disputes under Hatch-Waxman.
• Recovering an Inadvertently Produced Privileged Document: A Practical Guide: recovering privileged design-history material produced by mistake.

Related Checklists

• Doctrine of Equivalents Checklist: A Practical Checklist: the same process in check-off form.
• Post-Trial Motion Checklist: A Practical Checklist: post-trial deadlines and motions.

Related Toolkits

• Doctrine of Equivalents Toolkit: Claim Charts, Estoppel Histories, and Ensnarement Analyses: templates for the estoppel table, equivalents chart, Festo memo, hypothetical claim, expert outline, and JMOL motion.
• Section 112 Toolkit: Claim Support Charts, Invalidity Contentions, and Expert Declarations: support charts and contentions for the claims involved.
• Freedom to Operate and IP Clearance Toolkit: Clearing the Path Before You Launch: where equivalents analysis fits in clearance.
• Design Patent Toolkit: A Roadmap for Protecting How a Product Looks: for design patent matters.